Grupo Español de Tratamiento de Tumores de Cabeza y Cuello   Report issue

Academic/Hospital Phase 2
Founded: Madrid Spain (2001)

Organization Overview

First Clinical Trial
2008
NCT00765011
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Squamous Cell (Phase 2)

Head and Neck Neoplasms (Phase 2)

Laryngeal Neoplasms (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 7